Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ST LUKES COMMUNITY DEVELOPMENT CORPORATION - SUGAR LAND

NPI: 1659559573 · SUGAR LAND, TX 77478 · General Acute Care Hospital · NPI assigned 02/01/2008

$2.85M
Total Medicaid Paid
28,592
Total Claims
24,244
Beneficiaries
31
Codes Billed
2020-10
First Month
2024-11
Last Month

Provider Details

Authorized OfficialHARGIS, BRYAN (CHIEF EXECUTIVE OFFICER)
Parent OrganizationST. LUKES EPISCOPAL HEALTH SYSTEM CORPORATION
NPI Enumeration Date02/01/2008

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 326 $89K
2021 7,491 $968K
2022 8,122 $755K
2023 8,750 $840K
2024 3,903 $201K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 3,456 3,197 $1.85M
99283 Emergency department visit for the evaluation and management, moderate severity 5,162 4,941 $761K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 305 281 $71K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 521 507 $34K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 4,174 3,664 $31K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 343 301 $17K
87400 710 352 $13K
71045 Radiologic examination, chest; single view 492 450 $13K
80053 Comprehensive metabolic panel 1,433 1,226 $11K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 387 360 $10K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 419 407 $7K
70450 Computed tomography, head or brain; without contrast material 87 82 $6K
80048 Basic metabolic panel (calcium, ionized) 986 739 $6K
87807 303 295 $5K
81001 1,335 1,203 $4K
99282 Emergency department visit for the evaluation and management, low to moderate severity 27 25 $2K
71046 Radiologic examination, chest; 2 views 15 13 $2K
81025 129 119 $2K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 56 51 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 52 51 $1K
84484 469 389 $1K
96361 Intravenous infusion, hydration; each additional hour 16 13 $386.76
J2405 Injection, ondansetron hydrochloride, per 1 mg 26 24 $337.23
87081 26 26 $240.51
J7030 Infusion, normal saline solution , 1000 cc 205 179 $216.85
36415 Collection of venous blood by venipuncture 2,584 2,087 $139.71
85610 44 42 $88.08
82947 23 12 $3.14
A9270 Non-covered item or service 4,737 3,140 $0.83
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 43 41 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 27 27 $0.00